Markus Puhlmann
Chief Tech/Sci/R&D Officer bij PERSPECTIVE THERAPEUTICS, INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Markus Puhlmann is currently the Chief Medical Officer at Perspective Therapeutics, Inc. Prior to his current position, he served as the Head-Global Clinical Development at Seagen Inc. from 2019 to 2022.
Before that, he worked as a Principal at Merck & Co., Inc. from 2015 to 2019.
Dr. Puhlmann holds a doctorate degree from Ludwig-Maximilians-Universität München and an MBA from McDonough School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-04-2024 | 1 375 425 ( 0.23% ) | 2 M $ | 31-03-2024 |
Actieve functies van Markus Puhlmann
| Bedrijven | Functie | Begin |
|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Markus Puhlmann
| Bedrijven | Functie | Einde |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | 01-01-2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01-01-2019 |
Opleiding van Markus Puhlmann
| Ludwig-Maximilians-Universität München | Doctorate Degree |
| McDonough School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| PERSPECTIVE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
